We found that, despite high levels of Pdl1 expression and T cell infiltration, intestinal tumors from Apc-mutant mice with p16 epimutation are resistant to anti-PD-L1 treatment alone. This evidence concerns the gene CDKN2A and intestinal neoplasm.